Johnson & Johnson (JNJ)

$ 152.67
   
  • Change Today:
    $1.29
  • 52 Week High: $174.48
  • 52 Week Low: $144.45
  • Currency: US Dollars
  • Shares Issued: 2,407.08m
  • Volume: 1,459
  • Market Cap: $367,489m
  • RiskGrade: 87

ShareCast News

Sales of Johnson & Johnson Covid-19 vaccine reac... 20-Apr-2021 ShareCast
EU will not renew AstraZeneca and J&J contracts ... 14-Apr-2021 ShareCast
FDA halts J&J vaccination in US over rare blood ... 13-Apr-2021 ShareCast
J&J to supply 400m Covid-19 vaccine doses to Afr... 29-Mar-2021 ShareCast
Pfizer and BioNTech to accelerate deliveries of ... 16-Mar-2021 ShareCast
Johnson and Johnson 'confident' it can hit EU va... 12-Mar-2021 ShareCast
EU approves J&J Covid-19 vaccine for use in peop... 11-Mar-2021 ShareCast
US to achieve herd immunity by end of summer 2021 03-Mar-2021 ShareCast
Johnson and Johnson vaccine appears to be 'safe... 24-Feb-2021 ShareCast
J&J and Novavax Covid-19 vaccines still very muc... 18-Feb-2021 ShareCast
Johnson and Johnson Covid-19 vaccine 85% effecti... 29-Jan-2021 ShareCast
Johnson and Johnson expects Covid-19 trial resul... 26-Jan-2021 ShareCast
Johnson and Johnson Covid-19 vaccine may approve... 25-Jan-2021 ShareCast
Merck to refocus efforts on developing Covid-19 ... 25-Jan-2021 ShareCast
WHO warns of potential 'catastrophic moral failu... 18-Jan-2021 ShareCast
Johnson and Johnson's Covid-19 vaccine generates... 13-Jan-2021 ShareCast
Johnson and Johnson's Covid-19 vaccine approval ... 13-Jan-2021 ShareCast
Johnson & Johnson Covid vaccine trial results du... 13-Jan-2021 ShareCast
UK clears Moderna Covid-19 vaccine for use 08-Jan-2021 ShareCast
Reig Jofre to manufacture J&J coronavirus vaccin... 15-Dec-2020 ShareCast
Oxford Covid-19 vaccine produces immune response... 26-Oct-2020 ShareCast
Johnson & Johnson pauses Covid vaccine trial aft... 13-Oct-2020 ShareCast
Johnson & Johnson launches phase three clinical ... 23-Sep-2020 ShareCast
Fauci warns against premature EUA for Covid-19 v... 25-Aug-2020 ShareCast
Johnson & Johnson to buy Momenta Pharmaceuticals... 19-Aug-2020 ShareCast
Johnson & Johnson to supply 100m US Covid-19 vac... 05-Aug-2020 ShareCast
Johnson & Johnson to start human safety trial fo... 30-Jul-2020 ShareCast
US to start studies into three vaccine candidate... 10-Jun-2020 ShareCast
US open: Stocks record early gains following Chi... 31-Mar-2020 ShareCast
J&J to start Covid-19 vaccine trials by Septembe... 30-Mar-2020 ShareCast
US open: Shares down on 'hawkish' Fedspeak and a... 18-Oct-2019 ShareCast
Johnson and Johnson beats on Q3 EPS, raises full... 15-Oct-2019 ShareCast
Johnson & Johnson hit with $572m fine in landmar... 28-Aug-2019 ShareCast
Jury awards $29m to woman in Johnson & Johnson t... 14-Mar-2019 ShareCast
Johnson & Johnson ponders surgical robotics acqu... 23-Jan-2019 ShareCast
Johnson & Johnson predicts slower growth for 2019 22-Jan-2019 ShareCast
Strong demand for cancer drugs boosts Johnson & ... 16-Oct-2018 ShareCast
New York sues big pharma firms over role in opio... 24-Jan-2018 ShareCast
Johnson and Johnson raises full year targets aft... 17-Oct-2017 ShareCast
Johnson & Johnson faced with $417m payout after ... 22-Aug-2017 ShareCast
US open: Gains for WTI send S&P 500 back into re... 15-May-2017 ShareCast
Trump calls on drug giants to boost US productio... 31-Jan-2017 ShareCast
Johnson & Johnson agrees takeover of Actelion fo... 26-Jan-2017 ShareCast
Johnson & Johnson slumps despite 1.7% sales rise 24-Jan-2017 ShareCast
Actelion, Johnson & Johnson in exclusive talks 22-Dec-2016 ShareCast
Johnson & Johnson ditches talks with Actelion; S... 14-Dec-2016 ShareCast
AstraZeneca completes sale of US rights for nasa... 05-Dec-2016 ShareCast
Johnson&Johnson increases bid for Actelion 29-Nov-2016 ShareCast
US close: Gains for defensives send Wall Street ... 25-Nov-2016 ShareCast
Actelion surges on Johnson & Johnson bid report 25-Nov-2016 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Johnson and Johnson Market Data

Currency US Dollars
Share Price $ 152.67
Change Today $ 1.29
% Change 0.85 %
52 Week High $174.48
52 Week Low $144.45
Volume 1,459
Shares Issued 2,407.08m
Market Cap $367,489m
RiskGrade 87

What The Brokers Say

Strong Buy 5
Buy 6
Neutral 11
Sell 0
Strong Sell 0
Total 22
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 15-May-2024

Time Volume / Share Price
15:59 100 @ $152.70
15:59 100 @ $152.70
15:59 100 @ $152.68
15:59 100 @ $152.68
15:59 100 @ $152.68

Top of Page